GUGLIESI, Francesca
 Distribuzione geografica
Continente #
AS - Asia 93
EU - Europa 62
NA - Nord America 22
Totale 177
Nazione #
HK - Hong Kong 53
SG - Singapore 39
IT - Italia 29
US - Stati Uniti d'America 19
BE - Belgio 12
DE - Germania 9
LT - Lituania 5
CA - Canada 3
GB - Regno Unito 3
ES - Italia 2
FI - Finlandia 2
CN - Cina 1
Totale 177
Città #
Hong Kong 49
Singapore 35
Antwerp 8
Turin 8
Naples 7
Frankfurt am Main 5
Brussels 4
Munich 4
Boardman 3
Toronto 3
Fort Worth 2
Helsinki 2
Iesi 2
Santa Clara 2
Alcanar 1
Ashburn 1
Bilbao 1
London 1
Milan 1
Totale 139
Nome #
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 21
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 12
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 10
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 9
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease 9
50° Congresso Nazionale della Società Italiana di Microbiologia 9
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 9
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 8
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 8
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 8
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 8
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 7
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 7
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 7
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 7
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 7
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 7
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 7
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 7
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 6
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 6
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 6
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 5
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 5
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 5
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 3
Totale 203
Categoria #
all - tutte 1.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025203 0 38 55 9 39 53 9 0 0 0 0 0
Totale 203